- Home
- ONON vs ELAN Comparison
ONON vs ELAN Comparison
Compare ONON & ELAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ONON | ELAN |
|---|---|---|
| Founded | 2010 | 1954 |
| Country | Switzerland | United States |
| Employees | N/A | N/A |
| Industry | Shoe Manufacturing | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.0B | 11.8B |
| IPO Year | 2021 | 2018 |
Fundamental Metrics
Financial Performance| Metric | ONON | ELAN |
|---|---|---|
| Price | $37.94 | $22.94 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 20 | 10 |
| Target Price | ★ $60.15 | $27.89 |
| AVG Volume (30 Days) | ★ 5.9M | 5.8M |
| Earning Date | 05-12-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.11 |
| Revenue | N/A | ★ $4,715,000,000.00 |
| Revenue This Year | $19.58 | $8.21 |
| Revenue Next Year | $19.98 | $5.31 |
| P/E Ratio | ★ $56.05 | $208.00 |
| Revenue Growth | N/A | ★ 6.22 |
| 52 Week Low | $31.41 | $13.16 |
| 52 Week High | $55.95 | $27.72 |
Technical Indicators
Market Signals| Indicator | ONON | ELAN |
|---|---|---|
| Relative Strength Index (RSI) | 50.80 | 48.88 |
| Support Level | $31.52 | $22.04 |
| Resistance Level | $37.89 | $25.85 |
| Average True Range (ATR) | 1.26 | 1.10 |
| MACD | -0.20 | 0.03 |
| Stochastic Oscillator | 36.23 | 32.86 |
Price Performance
Historical ComparisonAbout ONON On Holding AG
Founded in Switzerland in 2010, sportswear firm On Holding generates 93% of its sales from athletic shoes. The brand is best known for its running shoes and its distinctive CloudTec soles. On also produces athletic apparel (6% of sales) and accessories (1%). The firm's merchandise is available in more than 80 countries and is sold through both wholesale (58% of sales) and company-owned channels (42%). In 2025, On generated 58% of its sales in North America, 25% in Europe, the Middle East, and Africa, and 17% in the Asia-Pacific region.
About ELAN Elanco Animal Health Incorporated
Elanco Animal Health is an animal health company that is engaged in developing, manufacturing, and marketing pharma products for companion and food animals. It spun off from Eli Lilly in 2018 and acquired Janssen Animal Health in 2011, Novartis Animal Health in 2014, Boehringer Ingelheim Vetmedica in 2017, and Bayer Animal Health in 2020. The company's operations are conducted globally, and it sells its products in over 90 countries. It offers a range of food animal products used in cattle, sheep, poultry, and swine production.